Search
Menu
Home
Sources
About
Contacts
Darglitazone
Darglitazone
is a member of the
class of drugs
and an
agonist
of
peroxisome proliferator-activated receptor-γ
, an
orphan
member of the
nuclear receptor
superfamily
of
transcription factors
. It has a
variety
of
insulin-sensitizing
effects
, such as
improving
glycemic
and lipidemic control, and was
researched
by
Pfizer
as a
treatment
of
metabolic disorders
such as.
Its
development
was terminated on
November 08
,
1999
.
Synthesis
